Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

New ACC/AHA guidelines detail updated recommendations for PCI, CABG

The new guidelines emphasize the importance of equal access to care among all patient populations, regardless of race or gender.

Autopsies suggest we still have a lot to learn about COVID-19's impact on the heart

Researchers focused on patients who died during the early stages of the pandemic.

Researchers 'really enthusiastic' about potential breakthrough in the treatment of vascular disease

The new treatment, still being tested in mice models, showed potential to help prevent future cardiovascular events in patients with vascular disease.

TEVAR outcomes don't suffer when performed at low-volume hospitals

Thoracic endovascular aortic repair, researchers wrote, "could be safely preformed across a wide range of hospitals regardless of their volume status."

DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib

Outcomes from patients prescribed apixaban, rivaroxaban or dabigatran were compared with outcomes from patients given warfarin.

DAPT after PCI can stop after 1 month, new research confirms

The study, published in the Journal of the American College of Cardiology, examined outcomes from more than 3,000 patients.

Some hospitalized COVID-19 patients may need anticoagulation therapy at discharge

Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.

Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee

The Disrupt BTK II study will include 250 patients overall.

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall